The MIRACL trial: Atorvastatin reduces recurrent ischemia post-ACS [Classics Series]
1. In patients with recent acute coronary syndrome, atorvastatin 80 mg daily reduced the risk of recurrent ischemia in the ...
1. In patients with recent acute coronary syndrome, atorvastatin 80 mg daily reduced the risk of recurrent ischemia in the ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.